(Q38337031)

2 September 2017

Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma (English)

1 reference

2 September 2017

0 references

1 reference

4

Linhardt RJ

1 reference

2 September 2017

Fath MA

1

1 reference

2 September 2017

Wu X

2

1 reference

2 September 2017

Hileman RE

3

1 reference

2 September 2017

Kashem MA

5

1 reference

2 September 2017

Nelson RM

6

1 reference

2 September 2017

Wright CD

7

1 reference

2 September 2017

Abraham WM

8

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

2 September 2017

273

1 reference

2 September 2017

13563-13569

1 reference

2 September 2017

22

1 reference

Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Heparin-induced conformational change and activation of mucus proteinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Rapid kinetic analysis of mechanochemical adenosinetriphosphatases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Colorimetric Method for Determination of Sugars and Related Substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

A sensitive new substrate for chymotrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Strong ionic interactions between mucins and two basic proteins, mucus proteinase inhibitor and lysozyme, in human bronchial secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Secretory leucocyte proteinase inhibitor is produced by human articular cartilage chondrocytes and intervertebral disc fibrochondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Mast cell chymase in complex with heparin proteoglycan is regulated by protamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Preparation and structural characterization of large heparin-derived oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Mapping the heparin-binding site of mucus proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

Inhibitors of human neutrophil cathepsin G: structural and biochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13563

21 January 2018

Identifiers

DOI

10.1074/JBC.273.22.13563

1 reference

2 September 2017

1 reference